世界のフィナステリド原薬市場予測 2023年-2029年

◆英語タイトル:Global Finasteride API Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23JU8202)◆商品コード:LP23JU8202
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のフィナステリド原薬市場」は、過去の販売実績から2022年の世界のフィナステリド原薬の総販売量を検討し、2023年から2029年の予測されるフィナステリド原薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のフィナステリド原薬の市場規模を掲載し、XXX百万米ドル規模の世界のフィナステリド原薬市場の詳細な分析を提供します。本インサイトレポートは、世界のフィナステリド原薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のフィナステリド原薬市場における各社の独自のポジションをより深く理解するために、フィナステリド原薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のフィナステリド原薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。フィナステリド原薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。フィナステリド原薬の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。フィナステリド原薬のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

フィナステリド原薬の世界主要メーカーとしては、AMRI、 Mylan、 Accord Pharmaceuticals、 Sterling Spa、 DEAFARMA、 Gadea Grupo Farmacéutico, S.L.U.、 Hetero、 Dr.Reddys Laboratories、 Pharmaffiliates、 Cipla、 Henan Topfond、 Khonsu International、 Aurobindo Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のフィナステリド原薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではフィナステリド原薬市場をセグメンテーションし、種類別 (純度99%以上、純度99%、純度99%以下)、用途別 (製薬業界、研究機関、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:純度99%以上、純度99%、純度99%以下

・用途別区分:製薬業界、研究機関、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のフィナステリド原薬市場の10年間の市場状況・展望は?
・世界および地域別に見たフィナステリド原薬市場成長の要因は何か?
・フィナステリド原薬の市場機会はエンドマーケットの規模によってどのように変化するのか?
・フィナステリド原薬のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:フィナステリド原薬の年間販売量2018-2029、地域別現状・将来分析
・フィナステリド原薬の種類別セグメント:純度99%以上、純度99%、純度99%以下
・フィナステリド原薬の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・フィナステリド原薬の用途別セグメント:製薬業界、研究機関、その他
・フィナステリド原薬の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のフィナステリド原薬市場
・企業別のグローバルフィナステリド原薬市場データ:2018-2023年の年間販売量、市場シェア
・企業別のフィナステリド原薬の年間売上:2018-2023年の売上、市場シェア
・企業別のフィナステリド原薬販売価格
・主要企業のフィナステリド原薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

フィナステリド原薬の地域別レビュー
・地域別のフィナステリド原薬市場規模2018-2023:年間販売量、売上
・主要国別のフィナステリド原薬市場規模2018-2023:年間販売量、売上
・南北アメリカのフィナステリド原薬販売の成長
・アジア太平洋のフィナステリド原薬販売の成長
・ヨーロッパのフィナステリド原薬販売の成長
・中東・アフリカのフィナステリド原薬販売の成長

南北アメリカ市場
・南北アメリカの国別のフィナステリド原薬販売量、売上(2018-2023)
・南北アメリカのフィナステリド原薬の種類別販売量
・南北アメリカのフィナステリド原薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のフィナステリド原薬販売量、売上(2018-2023)
・アジア太平洋のフィナステリド原薬の種類別販売量
・アジア太平洋のフィナステリド原薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のフィナステリド原薬販売量、売上(2018-2023)
・ヨーロッパのフィナステリド原薬の種類別販売量
・ヨーロッパのフィナステリド原薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のフィナステリド原薬販売量、売上(2018-2023)
・中東・アフリカのフィナステリド原薬の種類別販売量
・中東・アフリカのフィナステリド原薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・フィナステリド原薬の製造コスト構造分析
・フィナステリド原薬の製造プロセス分析
・フィナステリド原薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・フィナステリド原薬の主要なグローバル販売業者
・フィナステリド原薬の主要なグローバル顧客

地域別のフィナステリド原薬市場予測レビュー
・地域別のフィナステリド原薬市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・フィナステリド原薬の種類別市場規模予測
・フィナステリド原薬の用途別市場規模予測

主要企業分析
AMRI、 Mylan、 Accord Pharmaceuticals、 Sterling Spa、 DEAFARMA、 Gadea Grupo Farmacéutico, S.L.U.、 Hetero、 Dr.Reddys Laboratories、 Pharmaffiliates、 Cipla、 Henan Topfond、 Khonsu International、 Aurobindo Pharma
・企業情報
・フィナステリド原薬製品
・フィナステリド原薬販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
LPI (LP Information)’ newest research report, the “Finasteride API Industry Forecast” looks at past sales and reviews total world Finasteride API sales in 2022, providing a comprehensive analysis by region and market sector of projected Finasteride API sales for 2023 through 2029. With Finasteride API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Finasteride API industry.
This Insight Report provides a comprehensive analysis of the global Finasteride API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Finasteride API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Finasteride API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Finasteride API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Finasteride API.
The global Finasteride API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Finasteride API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Finasteride API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Finasteride API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Finasteride API players cover AMRI, Mylan, Accord Pharmaceuticals, Sterling Spa, DEAFARMA, Gadea Grupo Farmacéutico, S.L.U., Hetero, Dr.Reddys Laboratories and Pharmaffiliates, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Abrove 99% Purity
99% Purity
Under 99% Purity
Segmentation by application
Pharmaceutical Industry
Research Organization
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
AMRI
Mylan
Accord Pharmaceuticals
Sterling Spa
DEAFARMA
Gadea Grupo Farmacéutico, S.L.U.
Hetero
Dr.Reddys Laboratories
Pharmaffiliates
Cipla
Henan Topfond
Khonsu International
Aurobindo Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Finasteride API market?
What factors are driving Finasteride API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Finasteride API market opportunities vary by end market size?
How does Finasteride API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Finasteride API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Finasteride API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Finasteride API by Country/Region, 2018, 2022 & 2029
2.2 Finasteride API Segment by Type
2.2.1 Abrove 99% Purity
2.2.2 99% Purity
2.2.3 Under 99% Purity
2.3 Finasteride API Sales by Type
2.3.1 Global Finasteride API Sales Market Share by Type (2018-2023)
2.3.2 Global Finasteride API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Finasteride API Sale Price by Type (2018-2023)
2.4 Finasteride API Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Research Organization
2.4.3 Others
2.5 Finasteride API Sales by Application
2.5.1 Global Finasteride API Sale Market Share by Application (2018-2023)
2.5.2 Global Finasteride API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Finasteride API Sale Price by Application (2018-2023)
3 Global Finasteride API by Company
3.1 Global Finasteride API Breakdown Data by Company
3.1.1 Global Finasteride API Annual Sales by Company (2018-2023)
3.1.2 Global Finasteride API Sales Market Share by Company (2018-2023)
3.2 Global Finasteride API Annual Revenue by Company (2018-2023)
3.2.1 Global Finasteride API Revenue by Company (2018-2023)
3.2.2 Global Finasteride API Revenue Market Share by Company (2018-2023)
3.3 Global Finasteride API Sale Price by Company
3.4 Key Manufacturers Finasteride API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Finasteride API Product Location Distribution
3.4.2 Players Finasteride API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Finasteride API by Geographic Region
4.1 World Historic Finasteride API Market Size by Geographic Region (2018-2023)
4.1.1 Global Finasteride API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Finasteride API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Finasteride API Market Size by Country/Region (2018-2023)
4.2.1 Global Finasteride API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Finasteride API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Finasteride API Sales Growth
4.4 APAC Finasteride API Sales Growth
4.5 Europe Finasteride API Sales Growth
4.6 Middle East & Africa Finasteride API Sales Growth
5 Americas
5.1 Americas Finasteride API Sales by Country
5.1.1 Americas Finasteride API Sales by Country (2018-2023)
5.1.2 Americas Finasteride API Revenue by Country (2018-2023)
5.2 Americas Finasteride API Sales by Type
5.3 Americas Finasteride API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Finasteride API Sales by Region
6.1.1 APAC Finasteride API Sales by Region (2018-2023)
6.1.2 APAC Finasteride API Revenue by Region (2018-2023)
6.2 APAC Finasteride API Sales by Type
6.3 APAC Finasteride API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Finasteride API by Country
7.1.1 Europe Finasteride API Sales by Country (2018-2023)
7.1.2 Europe Finasteride API Revenue by Country (2018-2023)
7.2 Europe Finasteride API Sales by Type
7.3 Europe Finasteride API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Finasteride API by Country
8.1.1 Middle East & Africa Finasteride API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Finasteride API Revenue by Country (2018-2023)
8.2 Middle East & Africa Finasteride API Sales by Type
8.3 Middle East & Africa Finasteride API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Finasteride API
10.3 Manufacturing Process Analysis of Finasteride API
10.4 Industry Chain Structure of Finasteride API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Finasteride API Distributors
11.3 Finasteride API Customer
12 World Forecast Review for Finasteride API by Geographic Region
12.1 Global Finasteride API Market Size Forecast by Region
12.1.1 Global Finasteride API Forecast by Region (2024-2029)
12.1.2 Global Finasteride API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Finasteride API Forecast by Type
12.7 Global Finasteride API Forecast by Application
13 Key Players Analysis
13.1 AMRI
13.1.1 AMRI Company Information
13.1.2 AMRI Finasteride API Product Portfolios and Specifications
13.1.3 AMRI Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AMRI Main Business Overview
13.1.5 AMRI Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Finasteride API Product Portfolios and Specifications
13.2.3 Mylan Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Accord Pharmaceuticals
13.3.1 Accord Pharmaceuticals Company Information
13.3.2 Accord Pharmaceuticals Finasteride API Product Portfolios and Specifications
13.3.3 Accord Pharmaceuticals Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Accord Pharmaceuticals Main Business Overview
13.3.5 Accord Pharmaceuticals Latest Developments
13.4 Sterling Spa
13.4.1 Sterling Spa Company Information
13.4.2 Sterling Spa Finasteride API Product Portfolios and Specifications
13.4.3 Sterling Spa Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sterling Spa Main Business Overview
13.4.5 Sterling Spa Latest Developments
13.5 DEAFARMA
13.5.1 DEAFARMA Company Information
13.5.2 DEAFARMA Finasteride API Product Portfolios and Specifications
13.5.3 DEAFARMA Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 DEAFARMA Main Business Overview
13.5.5 DEAFARMA Latest Developments
13.6 Gadea Grupo Farmacéutico, S.L.U.
13.6.1 Gadea Grupo Farmacéutico, S.L.U. Company Information
13.6.2 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product Portfolios and Specifications
13.6.3 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Gadea Grupo Farmacéutico, S.L.U. Main Business Overview
13.6.5 Gadea Grupo Farmacéutico, S.L.U. Latest Developments
13.7 Hetero
13.7.1 Hetero Company Information
13.7.2 Hetero Finasteride API Product Portfolios and Specifications
13.7.3 Hetero Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hetero Main Business Overview
13.7.5 Hetero Latest Developments
13.8 Dr.Reddys Laboratories
13.8.1 Dr.Reddys Laboratories Company Information
13.8.2 Dr.Reddys Laboratories Finasteride API Product Portfolios and Specifications
13.8.3 Dr.Reddys Laboratories Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dr.Reddys Laboratories Main Business Overview
13.8.5 Dr.Reddys Laboratories Latest Developments
13.9 Pharmaffiliates
13.9.1 Pharmaffiliates Company Information
13.9.2 Pharmaffiliates Finasteride API Product Portfolios and Specifications
13.9.3 Pharmaffiliates Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Pharmaffiliates Main Business Overview
13.9.5 Pharmaffiliates Latest Developments
13.10 Cipla
13.10.1 Cipla Company Information
13.10.2 Cipla Finasteride API Product Portfolios and Specifications
13.10.3 Cipla Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cipla Main Business Overview
13.10.5 Cipla Latest Developments
13.11 Henan Topfond
13.11.1 Henan Topfond Company Information
13.11.2 Henan Topfond Finasteride API Product Portfolios and Specifications
13.11.3 Henan Topfond Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Henan Topfond Main Business Overview
13.11.5 Henan Topfond Latest Developments
13.12 Khonsu International
13.12.1 Khonsu International Company Information
13.12.2 Khonsu International Finasteride API Product Portfolios and Specifications
13.12.3 Khonsu International Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Khonsu International Main Business Overview
13.12.5 Khonsu International Latest Developments
13.13 Aurobindo Pharma
13.13.1 Aurobindo Pharma Company Information
13.13.2 Aurobindo Pharma Finasteride API Product Portfolios and Specifications
13.13.3 Aurobindo Pharma Finasteride API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Aurobindo Pharma Main Business Overview
13.13.5 Aurobindo Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Finasteride API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Finasteride API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Abrove 99% Purity
Table 4. Major Players of 99% Purity
Table 5. Major Players of Under 99% Purity
Table 6. Global Finasteride API Sales by Type (2018-2023) & (Tons)
Table 7. Global Finasteride API Sales Market Share by Type (2018-2023)
Table 8. Global Finasteride API Revenue by Type (2018-2023) & ($ million)
Table 9. Global Finasteride API Revenue Market Share by Type (2018-2023)
Table 10. Global Finasteride API Sale Price by Type (2018-2023) & (US$/Ton)
Table 11. Global Finasteride API Sales by Application (2018-2023) & (Tons)
Table 12. Global Finasteride API Sales Market Share by Application (2018-2023)
Table 13. Global Finasteride API Revenue by Application (2018-2023)
Table 14. Global Finasteride API Revenue Market Share by Application (2018-2023)
Table 15. Global Finasteride API Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Finasteride API Sales by Company (2018-2023) & (Tons)
Table 17. Global Finasteride API Sales Market Share by Company (2018-2023)
Table 18. Global Finasteride API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Finasteride API Revenue Market Share by Company (2018-2023)
Table 20. Global Finasteride API Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Finasteride API Producing Area Distribution and Sales Area
Table 22. Players Finasteride API Products Offered
Table 23. Finasteride API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Finasteride API Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global Finasteride API Sales Market Share Geographic Region (2018-2023)
Table 28. Global Finasteride API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Finasteride API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Finasteride API Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global Finasteride API Sales Market Share by Country/Region (2018-2023)
Table 32. Global Finasteride API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Finasteride API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Finasteride API Sales by Country (2018-2023) & (Tons)
Table 35. Americas Finasteride API Sales Market Share by Country (2018-2023)
Table 36. Americas Finasteride API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Finasteride API Revenue Market Share by Country (2018-2023)
Table 38. Americas Finasteride API Sales by Type (2018-2023) & (Tons)
Table 39. Americas Finasteride API Sales by Application (2018-2023) & (Tons)
Table 40. APAC Finasteride API Sales by Region (2018-2023) & (Tons)
Table 41. APAC Finasteride API Sales Market Share by Region (2018-2023)
Table 42. APAC Finasteride API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Finasteride API Revenue Market Share by Region (2018-2023)
Table 44. APAC Finasteride API Sales by Type (2018-2023) & (Tons)
Table 45. APAC Finasteride API Sales by Application (2018-2023) & (Tons)
Table 46. Europe Finasteride API Sales by Country (2018-2023) & (Tons)
Table 47. Europe Finasteride API Sales Market Share by Country (2018-2023)
Table 48. Europe Finasteride API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Finasteride API Revenue Market Share by Country (2018-2023)
Table 50. Europe Finasteride API Sales by Type (2018-2023) & (Tons)
Table 51. Europe Finasteride API Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa Finasteride API Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa Finasteride API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Finasteride API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Finasteride API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Finasteride API Sales by Type (2018-2023) & (Tons)
Table 57. Middle East & Africa Finasteride API Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Finasteride API
Table 59. Key Market Challenges & Risks of Finasteride API
Table 60. Key Industry Trends of Finasteride API
Table 61. Finasteride API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Finasteride API Distributors List
Table 64. Finasteride API Customer List
Table 65. Global Finasteride API Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global Finasteride API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Finasteride API Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas Finasteride API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Finasteride API Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC Finasteride API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Finasteride API Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe Finasteride API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Finasteride API Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa Finasteride API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Finasteride API Sales Forecast by Type (2024-2029) & (Tons)
Table 76. Global Finasteride API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Finasteride API Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global Finasteride API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. AMRI Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 80. AMRI Finasteride API Product Portfolios and Specifications
Table 81. AMRI Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. AMRI Main Business
Table 83. AMRI Latest Developments
Table 84. Mylan Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Finasteride API Product Portfolios and Specifications
Table 86. Mylan Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Accord Pharmaceuticals Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 90. Accord Pharmaceuticals Finasteride API Product Portfolios and Specifications
Table 91. Accord Pharmaceuticals Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Accord Pharmaceuticals Main Business
Table 93. Accord Pharmaceuticals Latest Developments
Table 94. Sterling Spa Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 95. Sterling Spa Finasteride API Product Portfolios and Specifications
Table 96. Sterling Spa Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Sterling Spa Main Business
Table 98. Sterling Spa Latest Developments
Table 99. DEAFARMA Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 100. DEAFARMA Finasteride API Product Portfolios and Specifications
Table 101. DEAFARMA Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. DEAFARMA Main Business
Table 103. DEAFARMA Latest Developments
Table 104. Gadea Grupo Farmacéutico, S.L.U. Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 105. Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product Portfolios and Specifications
Table 106. Gadea Grupo Farmacéutico, S.L.U. Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Gadea Grupo Farmacéutico, S.L.U. Main Business
Table 108. Gadea Grupo Farmacéutico, S.L.U. Latest Developments
Table 109. Hetero Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 110. Hetero Finasteride API Product Portfolios and Specifications
Table 111. Hetero Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Hetero Main Business
Table 113. Hetero Latest Developments
Table 114. Dr.Reddys Laboratories Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 115. Dr.Reddys Laboratories Finasteride API Product Portfolios and Specifications
Table 116. Dr.Reddys Laboratories Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Dr.Reddys Laboratories Main Business
Table 118. Dr.Reddys Laboratories Latest Developments
Table 119. Pharmaffiliates Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 120. Pharmaffiliates Finasteride API Product Portfolios and Specifications
Table 121. Pharmaffiliates Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Pharmaffiliates Main Business
Table 123. Pharmaffiliates Latest Developments
Table 124. Cipla Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 125. Cipla Finasteride API Product Portfolios and Specifications
Table 126. Cipla Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Cipla Main Business
Table 128. Cipla Latest Developments
Table 129. Henan Topfond Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 130. Henan Topfond Finasteride API Product Portfolios and Specifications
Table 131. Henan Topfond Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Henan Topfond Main Business
Table 133. Henan Topfond Latest Developments
Table 134. Khonsu International Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 135. Khonsu International Finasteride API Product Portfolios and Specifications
Table 136. Khonsu International Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. Khonsu International Main Business
Table 138. Khonsu International Latest Developments
Table 139. Aurobindo Pharma Basic Information, Finasteride API Manufacturing Base, Sales Area and Its Competitors
Table 140. Aurobindo Pharma Finasteride API Product Portfolios and Specifications
Table 141. Aurobindo Pharma Finasteride API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 142. Aurobindo Pharma Main Business
Table 143. Aurobindo Pharma Latest Developments
List of Figures
Figure 1. Picture of Finasteride API
Figure 2. Finasteride API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Finasteride API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Finasteride API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Finasteride API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Abrove 99% Purity
Figure 10. Product Picture of 99% Purity
Figure 11. Product Picture of Under 99% Purity
Figure 12. Global Finasteride API Sales Market Share by Type in 2022
Figure 13. Global Finasteride API Revenue Market Share by Type (2018-2023)
Figure 14. Finasteride API Consumed in Pharmaceutical Industry
Figure 15. Global Finasteride API Market: Pharmaceutical Industry (2018-2023) & (Tons)
Figure 16. Finasteride API Consumed in Research Organization
Figure 17. Global Finasteride API Market: Research Organization (2018-2023) & (Tons)
Figure 18. Finasteride API Consumed in Others
Figure 19. Global Finasteride API Market: Others (2018-2023) & (Tons)
Figure 20. Global Finasteride API Sales Market Share by Application (2022)
Figure 21. Global Finasteride API Revenue Market Share by Application in 2022
Figure 22. Finasteride API Sales Market by Company in 2022 (Tons)
Figure 23. Global Finasteride API Sales Market Share by Company in 2022
Figure 24. Finasteride API Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Finasteride API Revenue Market Share by Company in 2022
Figure 26. Global Finasteride API Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Finasteride API Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Finasteride API Sales 2018-2023 (Tons)
Figure 29. Americas Finasteride API Revenue 2018-2023 ($ Millions)
Figure 30. APAC Finasteride API Sales 2018-2023 (Tons)
Figure 31. APAC Finasteride API Revenue 2018-2023 ($ Millions)
Figure 32. Europe Finasteride API Sales 2018-2023 (Tons)
Figure 33. Europe Finasteride API Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Finasteride API Sales 2018-2023 (Tons)
Figure 35. Middle East & Africa Finasteride API Revenue 2018-2023 ($ Millions)
Figure 36. Americas Finasteride API Sales Market Share by Country in 2022
Figure 37. Americas Finasteride API Revenue Market Share by Country in 2022
Figure 38. Americas Finasteride API Sales Market Share by Type (2018-2023)
Figure 39. Americas Finasteride API Sales Market Share by Application (2018-2023)
Figure 40. United States Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Finasteride API Sales Market Share by Region in 2022
Figure 45. APAC Finasteride API Revenue Market Share by Regions in 2022
Figure 46. APAC Finasteride API Sales Market Share by Type (2018-2023)
Figure 47. APAC Finasteride API Sales Market Share by Application (2018-2023)
Figure 48. China Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Finasteride API Sales Market Share by Country in 2022
Figure 56. Europe Finasteride API Revenue Market Share by Country in 2022
Figure 57. Europe Finasteride API Sales Market Share by Type (2018-2023)
Figure 58. Europe Finasteride API Sales Market Share by Application (2018-2023)
Figure 59. Germany Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Finasteride API Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Finasteride API Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Finasteride API Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Finasteride API Sales Market Share by Application (2018-2023)
Figure 68. Egypt Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Finasteride API Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Finasteride API in 2022
Figure 74. Manufacturing Process Analysis of Finasteride API
Figure 75. Industry Chain Structure of Finasteride API
Figure 76. Channels of Distribution
Figure 77. Global Finasteride API Sales Market Forecast by Region (2024-2029)
Figure 78. Global Finasteride API Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Finasteride API Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Finasteride API Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Finasteride API Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Finasteride API Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のフィナステリド原薬市場予測 2023年-2029年(Global Finasteride API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆